e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
The ageing pulmonary interstitium
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Work of inflation is the best correlate to lung fibrosis induced by bleomycin in mice
J. E. Phillips, R. Peng, G. Tyagi, R. Garrido, L. Burns, P. Harris, J. S. Fine, C. S. Stevenson (Nutley, United States Of America)
Source:
Annual Congress 2011 - The ageing pulmonary interstitium
Session:
The ageing pulmonary interstitium
Session type:
Thematic Poster Session
Number:
786
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. E. Phillips, R. Peng, G. Tyagi, R. Garrido, L. Burns, P. Harris, J. S. Fine, C. S. Stevenson (Nutley, United States Of America). Work of inflation is the best correlate to lung fibrosis induced by bleomycin in mice. Eur Respir J 2011; 38: Suppl. 55, 786
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Late Breaking Abstract - PRRX1 inhibition decreases fibrosis in the bleomycin-induced lung fibrosis model in mice
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Interferon-γ pretreated human MSC show improved efficiency in humanized mice model of pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Aerobic exercise can impair lung fibrotic and functional response in a model of bleomycin-induced lung fibrosis: a time-dependent effect
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017
Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018
Enhanced lung inflammatory response to intratracheal CpG-ODN in mice with bleomycin-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Olodaterol attenuates bleomycin induced lung fibrosis in mice
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Bleomycin induced lung fibrosis in mice is attenuated by a new somatostatin analog
Source: Annual Congress 2006 - Matrix remodelling at the interface of lung fibrosis and emphysema
Year: 2006
Effect of Nintedanib in a rat model of lung fibrosis induced by single or double bleomycin administration
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
The effect of smoking to oxidative stress on lung tissue of rats with inhaled and intratracheal bleomycin induced pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007
Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation
versus
fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 396s
Year: 2006
Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice
Source: Eur Respir J 2005; 25: 708-714
Year: 2005
The histopathalogical evaluation of administration route of bleomycin in pulmonary fibrosis model and contribution of smoking to development of fibrosis
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007
Can curcuma inhibit bleomycin induced lung fibrosis in rats?
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Small airway reactivity is not altered in precision-cut lung slices from a bleomycin mouse model of airway fibrosis
Source: International Congress 2018 – Basic pharmacology
Year: 2018
The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept